Emtherapro is a biotech company that offers precision medicine enablement solutions for neurogenetic disorders.
Emtherapro has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Emtherapro is headquartered in Decatur, United States.
Emtherapro is a biotech company that offers precision medicine enablement solutions for neurogenetic disorders.
Emtherapro is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Emtherapro — Funding & Investors." VCBacked, September 7, 2023, https://www.vcbacked.co/company/emtherapro. Accessed November 12, 2026.
VCBacked. (2023). Emtherapro — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/emtherapro
{{cite web |title=Emtherapro — Funding & Investors |url=https://www.vcbacked.co/company/emtherapro |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Emtherapro? Request a listing update